Physician profile
Nickson Henry
NPI 1043247380
$2,291.25
in general payments reported to CMS, 2019-2025
14 companies · $472 in 2025
The $472 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $57.72 · 2021: $92.07 · 2022: $535 · 2023: $212 · 2024: $516 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $569.37 | 2022-2025 | Xiidra, Miebo, Infuse |
| Alcon Vision LLC | $500.56 | 2019-2025 | Precision7, Total30, Rocklatan |
| Coopervision INC. | $298.30 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Novartis Pharmaceuticals Corporation | $145.21 | 2019-2023 | |
| Maculogix, INC. | $127.17 | 2019 | |
| Glaukos Corporation | $118.56 | 2022 | |
| Optos, INC. | $107.14 | 2019 | |
| Oyster Point Pharma, INC. | $83.49 | 2024-2025 | Tyrvaya, Ryzumvi |
| Topcon Healthcare, INC. | $81.41 | 2023 | |
| Harrow Eye, LLC | $72.22 | 2024-2025 | Vevye |
| Lombart Brothers, INC. | $69.58 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $50.54 | 2019-2021 | |
| Abbvie INC. | $48.95 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $18.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickson Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.